Clinical trial for Dementia
Official title Dyadic, App-supported Collaborative Care Intervention Trial for Family Caregivers of People Living With Dementia
ClinicalTrials.gov ID: NCT07251088
What this study is testing
- What it's testing
- In Germany, approximately 1.8 million individuals are living with dementia, representing a considerable share of those requiring long-term care.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- formal dementia diagnosis
- living in their own home for the person with dementia
- access to a smartphone and internet for the informal caregiver
- informed consent of the participant
You likely can't join if
- not able to provide written consent
- if a legal representative is present, they may give their consent
The study team makes the final eligibility decision.
Where it is enrolling
- Reutlingen, Baden-Wurttemberg, Germany
- Darmstadt, Hesse, Germany
- Göttingen, Lower Saxony, Germany
- Greifswald, Mecklenburg-Vorpommern, Germany
- Rostock, Mecklenburg-Vorpommern, Germany
- Cologne, North Rhine-Westphalia, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Reutlingen, Baden-Wurttemberg, Germany; Darmstadt, Hesse, Germany; Göttingen, Lower Saxony, Germany; Greifswald, Mecklenburg-Vorpommern, Germany; Rostock, Mecklenburg-Vorpommern, Germany; Cologne, North Rhine-Westphalia, Germany. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.